Gefitinib was reported to be effective not only in lung cancers with EGFR mutations [23,24,28], but also for lung or colorectal cancers expressing EGFR protein or with increased EGFR gene copy number [20,29]. This evidence concerns the gene EGFR and lung carcinoma.